Related references
Note: Only part of the references are listed.Localized Immunotherapy via Liposome-Anchored Anti-CD137+IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
Brandon Kwong et al.
CANCER RESEARCH (2013)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
Diacylglycerol Kinases: Regulated Controllers of T Cell Activation, Function, and Development
Rohan P. Joshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
T and NK cells: two sides of tumor immunoevasion
Doriana Fruci et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Diacylglycerol Kinase a Is a Critical Signaling Node and Novel Therapeutic Target in Glioblastoma and Other Cancers
Charli L. Dominguez et al.
CANCER DISCOVERY (2013)
Regulation of lipid signaling by diacylglycerol kinases during T cell development and function
Sruti Krishna et al.
FRONTIERS IN IMMUNOLOGY (2013)
Melanoma Cells Inhibit NK Cell Functions-Letter
Giuseppe Sconocchia et al.
CANCER RESEARCH (2012)
Strain-Specific Variation in Murine Natural Killer Gene Complex Contributes to Differences in Immunosurveillance for Urethane-Induced Lung Cancer
Daniel Kreisel et al.
CANCER RESEARCH (2012)
High DGK-α and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention
Petra U. Prinz et al.
JOURNAL OF IMMUNOLOGY (2012)
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging
Judith Eckl et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The three main stumbling blocks for anticancer T cells
Lukas Baitsch et al.
TRENDS IN IMMUNOLOGY (2012)
Natural killer cells in non-hematopoietic malignancies
Melanie Desbois et al.
FRONTIERS IN IMMUNOLOGY (2012)
NK cells sense tumors, course of disease and treatments Consequences for NK-based therapies
Giulia Fregni et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity
C. J. Sanchez et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma
A. Perier et al.
ONCOGENE (2011)
Integration of Activating and Inhibitory Receptor Signaling by Regulated Phosphorylation of Vav1 in Immune Cells
Sven Mesecke et al.
SCIENCE SIGNALING (2011)
Activation or Tolerance of Natural Killer Cells Is Modulated by Ligand Quality in a Nonmonotonic Manner
Jayajit Das
BIOPHYSICAL JOURNAL (2010)
Treatment of metastatic renal cell carcinoma
David J. Reeves et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
The Current Role of Immunotherapy for Renal Cell Carcinoma in the Era of Targeted Therapeutics
Michael K. K. Wong
CURRENT ONCOLOGY REPORTS (2008)
Notch signaling induces cytoplasmic CD3ε expression in human differentiating NK cells
Magda De Smedt et al.
BLOOD (2007)
Perforin-dependent cryptococcal microbicidal activity in NK cells requires PI3K-dependent ERK1/2 signaling
Jeremy C. D. Wiseman et al.
JOURNAL OF IMMUNOLOGY (2007)
Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity
Xi Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma
JS Schleypen et al.
CLINICAL CANCER RESEARCH (2006)
Ligation of CD8α on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity
EG Addison et al.
IMMUNOLOGY (2005)
Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
JS Schleypen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Share Paper
